Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, ...

Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...

Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...

Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12, TD Cowen ...

Boston Scientific (NYSE:BSX) provides medical devices for gastrointestinal, pulmonary, urological, and neurological care, delivering advanced healthcare solutions worldwide.

Boston Scientific (NYSE:BSX) will have a transition at the top of its Cardiac Rhythm Management & Diagnostics (CRMDx) ...

In recent months, Parnassus Core Equity Fund disclosed a new position in Boston Scientific, while TD Cowen reiterated its ...

For me, buying a publicly traded stock is no different than buying an interest in a private business. In either case, I would only invest in a company that’s well-managed, with a valuable product line ...

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index ...